Nrx pharmaceuticals announces reverse stock split to maintain nasdaq listing

Common stock will begin trading on split-adjusted basis on april 2, 2024 radnor, pa. , march 28, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares.
NRXP Ratings Summary
NRXP Quant Ranking